Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Jones

Showing results (41-50 of 490) with videos related to

Pageof 49
Sort By:
Journal of Affective Disorders|January 15, 2018
Catechol O-methyltransferase (COMT) functional haplotype is associated with recurrence of affective symptoms: A prospective birth cohort studyShinsuke Koike, Darya Gaysina, Peter B Jones, et al.
Addiction (Abingdon, England)|March 17, 2007
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and WalesMatthew Hickman, Peter Vickerman, John Macleod, et al.
Social Psychiatry and Psychiatric Epidemiology|August 24, 2021
Understanding the excess psychosis risk in ethnic minorities: the impact of structure and identityHannah E Jongsma, Saffron Karlsen, James B Kirkbride, et al.
Bjpsych Open|January 29, 2021
More sensitive identification of psychotic experiences in common mental disorder by primary mental healthcare services - effect on prevalence and recovery: casting the net wider - CORRIGENDUMClare Knight, Debra Russo, Jan Stochl, et al.
The Lancet Regional Health. Europe|April 4, 2022
Prevalence, progress, and subgroup disparities in pharmacological antidepressant treatment of those who screen positive for depressive symptoms: A repetitive cross-sectional study in 19 European countriesShanquan Chen, Tamsin J Ford, Peter B Jones, et al.
The Lancet. Public Health|May 6, 2019
International incidence of psychotic disorders, 2002-17: a systematic review and meta-analysisHannah E Jongsma, Caitlin Turner, James B Kirkbride, et al.
Schizophrenia Research|March 8, 2021
Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohortBenjamin I Perry, Stanley Zammit, Peter B Jones, et al.
Bjpsych Open|November 6, 2020
More sensitive identification of psychotic experiences in common mental disorder by primary mental healthcare services - effect on prevalence and recovery: casting the net widerClare Knight, Debra Russo, Jan Stochl, et al.
The Lancet. Psychiatry|November 6, 2022
Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in CzechiaTomáš Formánek, Dzmitry Krupchanka, Karolína Mladá, et al.
Development and Psychopathology|January 8, 2025
A systematic review of pre-pandemic resilience factors and mental health outcomes in adolescents and young adults during the COVID-19 pandemicAnna Wiedemann, Radhika Gupta, Catherine Okey, et al.
Pageof 49

Showing results (41-50 of 490) with videos related to

Sort By:
Pageof 49
Journal of Affective Disorders|January 15, 2018
Catechol O-methyltransferase (COMT) functional haplotype is associated with recurrence of affective symptoms: A prospective birth cohort studyShinsuke Koike, Darya Gaysina, Peter B Jones, et al.
Addiction (Abingdon, England)|March 17, 2007
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and WalesMatthew Hickman, Peter Vickerman, John Macleod, et al.
Social Psychiatry and Psychiatric Epidemiology|August 24, 2021
Understanding the excess psychosis risk in ethnic minorities: the impact of structure and identityHannah E Jongsma, Saffron Karlsen, James B Kirkbride, et al.
Bjpsych Open|January 29, 2021
More sensitive identification of psychotic experiences in common mental disorder by primary mental healthcare services - effect on prevalence and recovery: casting the net wider - CORRIGENDUMClare Knight, Debra Russo, Jan Stochl, et al.
The Lancet Regional Health. Europe|April 4, 2022
Prevalence, progress, and subgroup disparities in pharmacological antidepressant treatment of those who screen positive for depressive symptoms: A repetitive cross-sectional study in 19 European countriesShanquan Chen, Tamsin J Ford, Peter B Jones, et al.
The Lancet. Public Health|May 6, 2019
International incidence of psychotic disorders, 2002-17: a systematic review and meta-analysisHannah E Jongsma, Caitlin Turner, James B Kirkbride, et al.
Schizophrenia Research|March 8, 2021
Childhood inflammatory markers and risks for psychosis and depression at age 24: Examination of temporality and specificity of association in a population-based prospective birth cohortBenjamin I Perry, Stanley Zammit, Peter B Jones, et al.
Bjpsych Open|November 6, 2020
More sensitive identification of psychotic experiences in common mental disorder by primary mental healthcare services - effect on prevalence and recovery: casting the net widerClare Knight, Debra Russo, Jan Stochl, et al.
The Lancet. Psychiatry|November 6, 2022
Mortality and life-years lost following subsequent physical comorbidity in people with pre-existing substance use disorders: a national registry-based retrospective cohort study of hospitalised individuals in CzechiaTomáš Formánek, Dzmitry Krupchanka, Karolína Mladá, et al.
Development and Psychopathology|January 8, 2025
A systematic review of pre-pandemic resilience factors and mental health outcomes in adolescents and young adults during the COVID-19 pandemicAnna Wiedemann, Radhika Gupta, Catherine Okey, et al.
Pageof 49